|
|
News Breaks | | | | January 9, 2012 | | 07:19 EDT |  | VRX | Valeant price target raised to $75 from $64 at Jefferies
Jefferies says Valeant's 2012 guidance was even better than its optimistic forecasts, and finds the company's goal of being a top 15 Pharma company by the end of 2013 intriguing. The firm says the goal would equate to a $160 per share valuation. Jefferies raised its price target for Valeant shares and keeps a Buy rating on the stock. | |
|
News For VRX From The Last 14 Days Check below for free stories on VRX the last two weeks. |
|
|
| May 17, 2013 | | 14:48 EDT |  | VRX | Actavis may bid for Warner Chilcott to ward off takeover, Reuters says
 Subscribe for More Information | | | 13:56 EDT |  | VRX | Actavis may purchase Warner Chilcott as takeover defense, Reuters reports
Over past few weeks, Actavis (ACT) has "spurned approaches" from Valeant (VRX) and Mylan (MYL), and has instead pursued a bid for Warner Chilcott (WCRX), according to Reuters, citing people familiar with the situation. | | | May 15, 2013 | | 19:37 EDT | | VRX | Novartis weighing Actavis bid, WSJ reports
Subscribe for More Information | | | May 14, 2013 | | 17:48 EDT | | VRX | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | | | 13:55 EDT | | VRX | Actavis weighing over $5B bid for Warner Chilcott, snubbed Mylan, Bloomberg says
Subscribe for More Information | | | May 10, 2013 | | 17:03 EDT | | VRX | Valeant announces information regarding continuance proposal
Subscribe for More Information | |
|
|
|
|
|
|
